Navigation Links
Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives
Date:7/9/2008

busy physicians," said Jamia Trigiani, founder and designer of The Detail Bag. "Since our original introduction of the detail bag we have received valuable feedback from pharmaceutical representatives and companies such as Eli Lilly, Astellas, Glaxo Smith Kline, Wyeth, Teva Spatiality, TPNA, Johnson and Johnson, Medicis, Roche, Proctor and Gamble, Sanoff-Aventis, Novartis, AstraZeneca and Skinceuticals. Based on this feedback we have introduced our second generation bag. This new sample case hits all the target criteria set by our industry."

The DB2 provides eight distinctive features to maximize organization.
Features of the DB2(sample case):

Sturdy Adjustable shelves - Allow reps to cleverly separate and organize product samples

Bottom-padded compartment - Offers accordion dividers; perfect for reprints, studies and forms, with ample space for a notebook computer

Personal pocket - Designed for easy access on the outside of the bag with a small zipped pocket for storing cell phones, business cards or other items, including a special hook for keys

Clear, gusseted side pocket - Displays and stores detail pieces that communicate the brand identity of products

Smooth rolling, durable In-line skate wheels - Provide smooth operation on rough surfaces

Telescoping toggle handle - Adjusts to accommodate reps of different heights, allowing for easy handling and ergonomic comfort.

Integrated bungee system - Secures extra sample cases or catered office lunches on top of the bag

Top and side carry handles - Allow for easy lifting in and out of the car

SkinCeuticals Chooses the Detail Bag II

In May, 2008 Skinceuticals of Garland, TX purchased the Detail Bag II as the new sample case of choice for its entire sales force. Mary Mills Kennedy, Skinceuticals Director of Training & Employee Development, comments about choosing the Detail Bag II. "We cho
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
2. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
3. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
4. South Texas Doctors Report More Severe Cases of Community Staph Super Bug Hospitalizing Children
5. Texas Aviation Services: Over 20 Years of Creating Flying Emergency Rooms for Airborne EMS Customers in US and Latin America
6. Dermatologists identify North Texas leishmaniasis outbreak
7. Precedent Launches Revolutionary Individual Health Insurance Plans in Texas
8. Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas
9. Sesame Street Exhibition Makes Texas Premier at The Health Museum
10. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
11. Viant Acquires Texas True Choice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives
Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...mab) drug is found to be useful in treating patien... by the European Medicines Agency (EMEA) for use i...rrent drugs//. Xolair can be used in the treatment...effects of the new drug on long time usage has to ...
... suggests that the melanocortin system is an impor...al neuronal plasticity observed after chronic morp... is accompanied by the development of morphine tol...ms associated with opiate treatment. Possible modu...
...m Italy have designed a closed circuit, where Umbi...n are performed, in order to reduce the contaminat...n//. Their findings appear in the journal Blood C...le online 19 August 2005)Umbilical cord blood is a...
...cal tourism is currently the buzz word of Indian h...g from USA and Canada for niche high cost orthoped...e replacement. // The fact that surgeries by many... and they have wide experience helps to win over t...
Other Medicine News:Health News:Inhibition of morphine tolerance by spinal melanocortin receptor blockade 2Health News:A Novel System For Clinical Banking Of Umbilical Cord Blood 2Health News:India - Favored Orthopedics Surgery Destination 2Health News:India - Favored Orthopedics Surgery Destination 3
(Date:9/5/2008)...lif., Sept. 5 /- SARcode,Co...cule LFA-1 inhibitors,to treat inflammatory diseas...S) today announced SARcode,s initiation of a Phase...t candidate for T-cell mediated ophthalmic,disease...ement providing,SARcode with an exclusive license ...
(Date:9/4/2008)...ept. 4 /- Cytopia Limited (ASX:,CYT) ...r its Phase Ib/II,study of CYT997, the company,s n...ents with an aggressive form of brain cancer known...cal trial is the first Phase II efficacy study in ...ompany and the second in its,suite of Phase II stu...
(Date:9/4/2008)...Man(R) real-time PCR testing for the diagnostic ...alif., Sept. 4 /- The U.S. Food & Dru...S(R) TaqMan(R) HBV Test,the first assay for quant...,The test uses Roche,s real-time PCR technology to... patient,s blood. Doctors may use viral load,testi...
(Date:9/4/2008)... 4 /- Southern Research Institute,tod...h (NIH) has selected,the organization to participa...roduction Center Network (MLPCN). The MLPCN -- a c...lecular Libraries Program which is,designed to ben... the human,genome and validate future targets for ...
Breaking Medicine Technology:SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 2SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases 3Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 1Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 2Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 3Coalition of Caregivers Warns Congress of Danger to Oldest U S Seniors if Medicare Slashed 5228 4New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus 28MRSA 29 1653 1New ActivePure Technology Proven To Reduce Exposure to Methicillin Resistant Staphylococcus Aureus 28MRSA 29 1653 2Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 1649 1Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 1649 2Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences 1649 3Mayo Clinic Study Shows Drug Could Effectively Treat Prevent the Spread of Breast Cancer 720 1Mayo Clinic Study Shows Drug Could Effectively Treat Prevent the Spread of Breast Cancer 720 2Mayo Clinic Study Shows Drug Could Effectively Treat Prevent the Spread of Breast Cancer 720 3
...Abbott,s Bioabsorbable Stent Technology Holds Prom...icians Treating Patients,with Coronary Artery Dise...-FirstCall/ --,Abbott today announced positive res... evaluating the overall safety and performance,of ... for the,treatment of coronary artery disease. Six...
...Initial Analysis Shows Statistically Significant C... ALTO, Calif., March 26, 2007 /PRNewswire-FirstCal... positive initial,results from its Phase IIa clini...zophrenic patients with acute agitation. The 10 mg...inical trial,which was a statistically-significan...
Other Medicine Technology:Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 2Abbott Announces Positive Six-Month Results From the World's First,Clinical Trial of a Fully Bioabsorbable Drug-Eluting Coronary Stent 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 2Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 3Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 4Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 5Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation 6
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
...ratory and a worldwide leader in innovative labora...nsive test menu of highly complex and unique medic... by the University of Utah, ARUP Laboratories' cli...sity teaching hospitals and children's hospitals, ...
Medicine Products: